Should investors be afraid of coal stocks like Arch Coal (ACI), Alpha Natural Resources (ANR) and Peabody Energy (BTU)? Yes, unless they happen to be very long-term investors, says JPMorgan’s John Bridges and team:
ASSOCIATED PRESSThe coal equities have fallen two-thirds from their 2011 peak as supply has overtaken faltering demand. We remain convinced that coal is an essential base load fuel source for the US and other�� power grids. This situation is probably offering opportunities for farsighted investors. It was interesting that recently Chris Cline secured control over 480mt of permitted coal in Canada. Last year, Kinder Morgan announced plans to buy royalties on coal so it could benefit at the exports ports and at the source of the coal. Without seeing any near term catalysts that can lift coal prices and with their often elevated debt levels buying the listed equities is a more risky strategy. We do see real long term value in the coal equities with the better balance sheets. However, given the growing supplies of nat gas, without a chilly winter, gas prices could weaken further, and create a better buying opportunity for the coal space. In this environment, coal bulls seems to have been seeing tax loss selling as a better opportunity than hanging on, and deep value buyers are failing to see positive catalysts…
Top 5 Defense Companies To Own For 2015: Proofpoint Inc (PFPT)
Proofpoint, Inc. (Proofpoint), incorporated in 2002, is a security-as-a-service vendor that delivers data protection solutions, which helps medium- and large-sized organizations worldwide. Proofpoint�� security-as-a-service platform consists of an integrated suite of on-demand data protection solutions, including threat protection, regulatory compliance, archiving and governance, and secures communication. It provides a multi-tiered security-as-a-service platform consisting of solutions, platform technologies and infrastructure. The Company�� security-as-a-service platform includes four solutions bundled for the convenience of its customers: Proofpoint Enterprise Protection, Proofpoint Enterprise Privacy, Proofpoint Enterprise Archive and Proofpoint Enterprise Governance. Its platform services consist of content inspection, reputation, encryption and key management, notification and workflow, and analytics and search. During the year ended December 31, 2011, the Company acquired NextPage, Inc. In September 2013, Proofpoint Inc completed its acquisition of Armorize Technologies Inc. In October 2013, the Company acquired Silicon Valley based Sendmail, Inc.
The Company�� solutions are used by approximately 2,400 customers worldwide, including 26 of the Fortune 100, protecting tens of millions of end-users. It markets and sells its solutions worldwide both directly through the sales teams and indirectly through a hybrid model. It also distributes its solutions through International Business Machines Corp. (IBM), Microsoft Corporation and VMware, Inc.
Proofpoint Enterprise Protection
Proofpoint Enterprise Protection is the Company�� communications and collaboration security suite designed to protect customers' mission-critical messaging infrastructure from outside threats including spam, phishing, unpredictable e-mail volumes, malware and other forms of objectionable or dangerous content before they reach the enterprise. Key capabilities within proofpoint en! terprise protection include threat detection, virus protection, zero-hour threat detection and smart search.
Proofpoint Enterprise Privacy
The Company�� data loss prevention, encryption and compliance solution defends against leaks of confidential information, and helps ensure compliance with common United States, international and industry-specific data protection regulations, including HIPAA, GLBA, PIPEDA and PCI-DSS. Key capabilities within Proofpoint Enterprise Privacy include Advanced data loss prevention, Flexible remediation and supervision, Policy-based encryption and Secure file transfer.
Proofpoint Enterprise Archive
Proofpoint Enterprise Archive is designed to ensure accurate enforcement of data governance, data retention and supervision policies and mandates; cost effective litigation support through discovery, and active legal hold management. Proofpoint Enterprise Archive can store, govern and discover a range of data, including e-mail, instant message conversations, social media interactions, and other files throughout the enterprise. The key capabilities within Proofpoint Enterprise Archive include Secure cloud storage, Search performance, Flexible policy enforcement, Active legal-hold management and End-user supervision.
Proofpoint Enterprise Governance
Proofpoint Enterprise Governance provides organizations the ability to track, classify, monitor, and apply governance policies to unstructured information across the enterprise. The key capabilities within Proofpoint Enterprise Governance include Document Tracking-Digital Thread, Cloud-based Search and Analytics, and Flexible policy enforcement.
The Company competes with Cisco Systems, Inc., EMC Corporation, Google Inc., Hewlett-Packard Company, Intel and Microsoft.
Advisors' Opinion:- [By Sean Williams]
One company in particular I'd suggest putting back on the sales rack is Proofpoint (NASDAQ: PFPT ) , a threat and regulatory security-as-a-service provider. The profit potential is certainly there. Proofpoint's SaaS model is built around getting the client hooked on its products and making it inconvenient and cost-inefficient for them to switch to a competitor. In other words, it's setting up its own razor-and-blades model that should fuel recurring revenue for years to come.
Hot Net Payout Yield Companies To Buy Right Now: Ambit Biosciences Corp (AMBI)
Ambit Biosciences Corporation, incorporated on May 17, 2000, is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company�� lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML). The Company�� second drug candidate in clinical development, AC410, is a potent, selective, orally-administered, small molecule inhibitor of Janus kinase 2 (JAK2) that has potential utility for the treatment of autoimmune and inflammatory diseases. The Company�� third program consists of two selective small molecule compounds, AC708 and AC855, which inhibit the colony-stimulating factor-1 receptor (CSF1R), a receptor tyrosine kinase.
Quizartinib
The Company�� lead drug candidate, quizartinib, is a once-daily, orally-administered, potent and selective inhibitor of FLT3, a validated target in the treatment of AML, and is in Phase IIb clinical development. The FLT3-ITD mutation acts like a power switch that causes leukemic cells, or blasts, to spread more aggressively and grow back more rapidly following chemotherapy, conferring an especially poor survival outcome. Quizartinib is designed to turn off this switch. The Company is developing a companion diagnostic test with Genoptix Medical Laboratory, a Novartis company, to identify FLT3-ITD positive patients.
AC410
The Company�� advanced drug candidate, AC410, is a potent, selective, orally-administered, small molecule inhibitor of JAK2, which has potential utility for the treatment of autoimmune and inflammatory diseases. Signaling through JAK controls the activation, proliferation and survival of various types of immune cells, and overactivation of such cells can exacerbate a range of normal inflammatory processes, resulting i! n inflammation. The Company�� initial JAK2 drug candidate, AC430, is a racemic mixture (50/50) of two enantiomers (mirror images), AC410 and AC409, and was studied in a Phase I clinical trial.
CSF1R Program
The Company is developing two potent and exquisitely selective small molecule compounds, AC708 and AC855 that both inhibit CSF1R and have potential utility in oncology, autoimmune and inflammatory diseases. Signaling through CSF1R controls the activation, proliferation and survival of macrophages, which are key mediators of immune system function and over-activation of macrophages, may result in exacerbation of certain diseases.
The Company competes with Abbvie Inc., Akinion Pharmaceuticals AB, Amgen Inc., ARIAD Pharmaceuticals, Inc., AROG Pharmaceuticals, LLC, ArQule, Inc., Astellas, AstraZeneca plc, Bayer AG, Celgene Corporation, Daiichi-Sankyo Company Limited, Galapagos NV, GlaxoSmithKline plc, Incyte Corporation, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Eli Lilly and Company, Novartis, Onyx Pharmaceuticals, Inc., Pfizer, Rigel Pharmaceuticals, Inc., F. Hoffman-LaRoche Ltd, and Vertex Pharmaceuticals Incorporated.
Advisors' Opinion:- [By Wallace Witkowski]
Ambit Biosciences Corp. (AMBI) �shares fell more than 37% to $8 in moderate volume. The small-cap biotech said it will not file an accelerated approval application with the Food and Drug Administration for its leukemia drug quizartinib after the agency disagreed with the company about the use of certain study data to support the drug�� efficacy.
Hot Net Payout Yield Companies To Buy Right Now: Parametric Sound Corp (PAMT)
Parametric Sound Corporation (Parametric Sound), incorporated on June 2, 2010, is a technology company focused on delivering audio solutions through its HyperSound (HSS(r)) technology platform, which consists of the practical application of parametric acoustic technology for generating sound along a directional ultrasonic column. In addition to its commercial product business, the Company is targeting its technology for new uses in consumer markets including computers, video gaming, televisions and home audio along with other commercial markets including casino gaming and cinema. The Company is also researching and developing health applications for persons with hearing loss. The Company's principal markets for its products are North America, Europe and Asia. In October 2012, the Company formed HyperSound Health, Inc. (HHI) as wholly owned subsidiary. In January 2014, Parametric Sound Corp completed its merger with privately-held Turtle Beach.
Its commercial product line, HSS-3000, delivers directed audio solutions to customers primarily for digital signage, point-of-purchase, in-store network and related applications. Its commercial HSS-3000 HyperSound Audio System consists of a HSS-3000 Amplifier and one or more HSS-3000 Emitters. The HSS-3000 Emitter features a 5-inch by 10-inch emitter surface and is separate from the amplifier, offering varied installation options. It offers a variety of supporting installation hardware for customers.
The Company competes with Harmon International Industries, Bose, Klipsch, Polk Audio, Pioneer, Sony, Boston Acoustics, LG, Samsung, Brown Innovations, Inc. Panphonics and Holosonic Research Labs, Inc.
Advisors' Opinion:- [By John Udovich]
Yesterday after the market closed, small cap audio stock Skullcandy Inc (NASDAQ: SKUL) reported earnings and began rising in after hours trading, meaning its worth taking a closer look at the stock along with the performance of other audio stocks like mid cap Harman International Industries Inc (NYSE: HAR) and small caps Koss Corporation (NASDAQ: KOSS) and Parametric Sound Corp (NASDAQ: PAMT). I should mention that in�late 2012, Skullcandy had the dubious distinction of being the market�� most shorted stock (see: Long Live the Shorts or the Short Squeeze? SKUL, AM & UBNT) with short�interest of 86.47% and there would still be a lot of shorts out there who might start feeling the squeeze (Note: SKUL is at least no longer on the HighShortInterest.com list)
Hot Net Payout Yield Companies To Buy Right Now: SAP AG(SAP)
SAP AG provides business software primarily in Europe, the Middle East, Africa, the Americas, and the Asia Pacific Japan region. The company?s products includes SAP Business Suite software, which supports large organizations in their core business operations, such as supplier relationship, production, warehouse management, sales, administration, and customer relationship; SAP Business All-in-One, a business management software that assists midsize companies in managing various business functions, including financials, human resources, procurement, inventory, manufacturing, logistics, product development, sales, and marketing; SAP Business One, a business management application for small businesses; and SAP Business ByDesign, an on-demand solution for integrated business management applications. Its products also comprises SAP BusinessObjects Edge business intelligence and enterprise performance management solutions; Xcelsius, a data visualization software; Crystal Reports, which helps users design interactive reports; Sybase IQ, an optimized analytics server designed to deliver results for business intelligence, analytics, data warehousing, and reporting solutions; SAP solutions for sustainability; and SAP NetWeaver technology platform, which integrates information and business processes across various technologies and organizational structures. In addition, the company offers industry and solution-focused, business transformation, information technology transformation, custom development, and support services; and program, project management, quality assurance, and education and certification services. It sells its products through its subsidiaries and resellers. SAP AG has a strategic relationship with Cap Gemini S.A. to develop and deploy enterprise mobility solutions. The company was formerly known as SAP Aktiengesellschaft Systeme, Anwendungen, Produkte in der Datenverarbeitung. SAP AG was founded in 1972 and is headquartered in Walldorf , Germany.
Advisors' Opinion:- [By Paul Ausick]
Big Earnings Movers: McDonald�� Corp. (NYSE: MCD) is down 0.6% at $94.59 after a so-so report and a downbeat forecast. Halliburton Co. (NYSE: HAL) is down 3.4% at $50.67 on added caution for the current quarter. V.F. Corp. (NYSE: VFC) is up 3.4% at $211.24. SAP AG (NYSE: SAP) is up 3.6% at $76.38. NVR Corp. (NYSE: NVR) is down 4.1% at $893.40.
No comments:
Post a Comment